KOSDAQ · Healthcare · ₩174B
₩5,990+3.45%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.5% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“신사업 제품이 실적 회복을 이끌며 다음 성장을 준비해요.”
In the company's words · 2026 2분기 filing